CClinicalTrials.gg
RecruitingNCT06509425Updated Jul 19, 2024

Pelvic Congestion Syndrome Post Tubal Ligation Versus Salpingectomy Performed During Caesarean Section

An interventional study of salpingectomy during caesarean section and tubal ligation during caesarean section in Pelvic Congestion Syndrome, sponsored by Ain Shams University. Recruiting at 1 site in Egypt. Open to female participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-19.

Sponsored by Ain Shams University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
30 Years and older
Sex
Female
01

Study summary

Permanent tubal sterilization during Caesarean section is a reliable method of contraception. It is done either by bilateral tubal ligation or bilateral salpingectomy according to surgeon's preference.

Studies revealing bilateral salpingectomy has an added benefit of primary prevention of ovarian cancer has encouraged surgeons to perform bilateral salpingectomy rather than tubal ligation as a risk reducing surgery owing to the acceptance of fallopian tubes as the origin of high grade serous ovarian cancer.

Another aspect to take into consideration is the post tubal ligation syndrome as it severely affects the quality of life. Diagnosis is based on clinical picture, imaging, and exclusion of other causes of chronic pelvic pain. Women experience dysmenorrhea, dyspareunia, menstrual irregularities, and pelvic pain. The gold standard is venography; however, the first choice for initial evaluation is duplex ultrasound.

In this study, we assess impact of bilateral salpingectomy versus tubal ligation in terms of pelvic congestion by participant's symptoms and ultrasound findings

Read the detailed description

Women planned for caesarean delivery and tubal sterilization will be screened for eligibility on presenting to the labor unit.

Informed written consent will be taken from all the participants before enrollment in the study.

Randomization will be done at a 1:1 ratio to bilateral salpingectomy or bilateral tubal ligation by a computer-generated scheme. Sequentially numbered sealed opaque envelopes will be prepared, each containing patient allocated procedure. It will be revealed to the case surgeon.

  1. Surgical Intervention: Caesarean section and tubal sterilization will be performed by resident on duty.

Identification of the fimbriated end of the Fallopian tube. It will be grasped by a Babcock or Allis forceps.

Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.

Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.

Hemostasis will be ensured at the incised edges. Participants undergoing salpingectomy will have their fallopian tubes sent for pathological examination to confirm transection and exclude malignancies.

  1. Postoperative assessment: Follow up visit after ten weeks.
  1. History:

    The participant is asked about these symptoms:

    • Menstrual irregularities
    • Dull, noncyclical throbbing pelvic pain (unilateral or bilateral), worsened with long periods of standing or walking and punctuated by intermittent sharp pain.
  2. Sonographic evaluation:

It will be done by the same investigator (Assistant Lecturer at Radiology department, Ain Shams University).

Machine used:

Samsung ultrasound machine with Transvaginal probe 5-7 Megahertz

All participants will be asked to empty their urinary bladder and will be placed in lithotomy position with adequate covering of the participants for transvaginal position. The assessment will detect:

  1. Presence of pelvic varicocele. (tortuous and dilated veins that are greater than 6 mm in diameter around the ovary and uterus)
  2. Maximal diameter of the pelvic venous plexus.
  3. Presence of crossing veins in the myometrium.
  4. Change of the duplex waveform during Valsalva's maneuver in both ovarian and internal iliac veins.
02

Conditions studied

  • Pelvic Congestion Syndrome

Browse trials for

Keywords

  • salpingectomy
  • pelvic congestion
  • tubal ligation
03

In context

Syndrome

9,215 studies on the registry are indexed under Syndrome; 1,029 are open to participants now.

This study's planned enrollment of 64 is above the median of 50 across 6,513 interventional studies indexed under Syndrome.

Browse Syndrome studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,879 studies on the registry; 424 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Females undergoing caesarean section and requesting tubal sterilization as a permanent method of contraception.
  • 30 years or older

Exclusion criteria

Exclusion Criteria:

  • Previous history of tubal surgery (changes in blood flow)
  • Previous history of oophorectomy (changes in blood flow)
  • Congenital anomalies or malformations in fallopian tubes or ovaries. (affection of normal anatomy of pelvic blood vessels)
  • Women diagnosed with pelvic congestion. (Known cause for pelvic congestion other than tubal sterilization)
  • High likelihood of lost to follow up.
  • Inability to provide good data.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Participants undergoing caesarean section and salpingectomy.

    Procedure: salpingectomy during caesarean section

  • Active comparator
    Participants undergoing caesarean section and tubal ligation

    Procedure: tubal ligation during caesarean section

Interventions

  • Proceduresalpingectomy during caesarean section

    Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.

  • Proceduretubal ligation during caesarean section

    Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.

06

What researchers measure

Primary outcomes

  1. symptoms of pelvic congestion syndrome

    A questionnaire to detect changes in menstrual pattern or new onset of pelvic pain.

    Time frame: Ten weeks postoperative

Secondary outcomes

  1. signs of pelvic congestion syndrome

    Transvaginal US will be done 10 weeks postoperative for detection of signs of pelvic congestion

    Time frame: Ten weeks postoperative

  2. intraoperative complications

    blood transfusion, visceral injury and increased operative time

    Time frame: intraoperative

07

Study locations

1 of 1 sites recruiting
  • Ain Shams Maternity Hospitals
    Cairo, Abaseya 11588, Egypt
    • maternity H · Contact · 0224346001
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — A case report form for each participant will be shared.

Supporting information: Study protocol, Sap, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06509425
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Jul 19, 2024
Start date
May 21, 2024
Primary completion
Sep 2024 (estimated)
Completion
Sep 2024 (estimated)
Last update
Jul 19, 2024

Study contacts

Mayar Z Kamal
Contact
mayarziad2@gmail.com

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion